CN Patent

CN105708792A — 一种还原型羧烷基葡聚糖铁注射液及其制备方法

Assigned to Shanxi Powerdone Pharmaceutical Co Ltd · Expires 2016-06-29 · 10y expired

What this patent protects

本申请提供了一种还原型羧烷基葡聚糖铁注射液，其包括作为活性成分的还原型羧烷基葡聚糖铁，任选的酸碱调节剂和注射用水。本申请还提供了一种还原型羧烷基葡聚糖铁注射液的制备方法。本申请所提供的注射液具有比现有技术获得的铁注射液更低的可见异物检出率，具有良好的性能如物理稳定性好和/或化学稳定性好。

USPTO Abstract

本申请提供了一种还原型羧烷基葡聚糖铁注射液，其包括作为活性成分的还原型羧烷基葡聚糖铁，任选的酸碱调节剂和注射用水。本申请还提供了一种还原型羧烷基葡聚糖铁注射液的制备方法。本申请所提供的注射液具有比现有技术获得的铁注射液更低的可见异物检出率，具有良好的性能如物理稳定性好和/或化学稳定性好。

Drugs covered by this patent

Patent Metadata

Patent number
CN105708792A
Jurisdiction
CN
Classification
—
Expires
2016-06-29
Drug substance claim
No
Drug product claim
No
Assignee
Shanxi Powerdone Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.